ArticleProtein science : a publication of the Protein Society2026
ConforFold recovers alternative protein conformations beyond MSA subsampling.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Conformational changes underlie many aspects of protein function, yet current structure prediction tools remain limited in their ability to systematically sample structural ensembles. Here, we present ConforPSSP and ConforFold, a combined framework that integrates secondary-structure sampling into a deep learning-based prediction to recover multiple protein conformational states. ConforPSSP employs a transformer model trained on multi-residue fragments to generate diverse 8-state protein secondary structure predictions (PSSPs), which are then used to condition a retrained OpenFold model (ConforFold). ConforFold achieved state-of-the-art performance in conformer recovery. On our test dataset of protein samples with two alternative conformations, it correctly identified both conformers in 84% of cases at TM-scores ≥0.8, outperforming AlphaFlow (75.4%), which uses diffusion-based sampling, and Cfold, which relies on MSA clustering. It outperformed BioEmu, a novel method that emulates MD simulation results, in cases where secondary structures between conformers differ significantly (83% and 76% of cases for ConforFold and BioEmu, respectively). These results establish ConforFold as a broadly applicable framework for modeling structural ensembles. It recovers conformations inaccessible to MSA-based subsampling or diffusion models by explicitly integrating secondary structure, offering a new avenue for investigating conformational heterogeneity, mechanistic transitions, and the structural basis of protein function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.